Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy — Ralf Weiskirchen (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
RW
Shared by
Ralf Weiskirchen
Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
Letter
2023
en
Authors
RW
Ralf Weiskirchen
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Small-Molecule Inhibitor Targeting Protein Kinase D: A Potential Therapeutic Strategy
Die Lv
,
Hongli Chen
,
Yun Feng
,
Bomiao Cui
,
Yingzhu Kang
,
Ping Zhang
,
Min Luo
,
Jiao Chen
Frontiers in Oncology
Editorial Material
2017
Editorial: Regulation of Inflammation, Its Resolution and Therapeutic Targeting
Mariagrazia Uguccioni
,
Mauro Martins Teixeira
,
Massimo Locati
,
Alberto Mantovani
Article
2014
The therapeutic value of targeting inflammation in gastrointestinal cancers
Beicheng Sun
,
Michael Karin
Article
2019
Targeting macrophage immunometabolism to prevent atherosclerosis
Luke O'neill
Nature Metabolism
Article
2019
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Mansour Sedighi
,
Abed Zahedi Bialvaei
,
Michael R Hamblin
,
Elnaz Ohadi
,
Arezoo Asadi
,
Masoumeh Halajzadeh
,
Vahid Lohrasbi
,
Nima Mohammadzadeh
,
Taghi Amiriani
,
Marcela Krůtová
,
Abolfazl Amini
,
Ebrahim Kouhsari
Discussion(0)
No comments yet. Be the first to comment.